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Abstract: Mastitis is an infectious disease encountered in dairy animals worldwide that is currently a
growing concern in Lebanon. This study aimed at investigating the etiology of the main mastitis-
causing pathogens in Northern Lebanon, determining their antimicrobial susceptibility profiles, and
identifying their antimicrobial resistance (AMR) genes. A total of 101 quarter milk samples were
collected from 77 cows and 11 goats presenting symptoms of mastitis on 45 dairy farms. Bacterial
identification was carried out through matrix-assisted laser desorption/ionization-time of flight
mass spectrometry. Antimicrobial susceptibility was tested by disc diffusion and broth microdilu-
tion methods. Molecular characterization included polymerase chain reaction (PCR) screening for
genes encoding extended-spectrum beta-lactamases (ESBLs) and plasmid-mediated AmpC among
Enterobacterales isolates, and virulence factors among Staphylococcus isolates. Escherichia coli isolates
were subjected to phylogenetic typing by a quadruplex PCR method. The most frequently identified
species were Streptococcus uberis (19.2%), Streptococcus agalactiae (15.1%), E. coli (12.3%), and Staphylo-
coccus aureus (10.96%). Gram-positive bacteria were resistant to macrolides and tetracycline, whereas
gram-negative bacteria displayed resistance to ampicillin and tetracycline. Two ESBL genes, blaTEM
(83.3%) and blaOXA (16.7%), and one AmpC beta-lactamase gene, blaCMY-II (16.7%), were detected
among six E. coli isolates, which mainly belonged to phylogenetic group B1. Among Staphylococcus
spp., the mecA gene was present in three isolates. Furthermore, four isolates contained at least one
toxin gene, and all S. aureus isolates carried the ica operon. These findings revealed the alarming risk
of AMR in the Lebanese dairy chain and the importance of monitoring antimicrobial usage.
Keywords: mastitis; antimicrobial resistance; molecular epidemiology; beta-lactamase; one health;
virulence; biofilm; Lebanon
1. Introduction
Mastitis is by far the most widespread and costly disease in dairy cattle worldwide. It
has severe and significant economic consequences that include losses in milk production,
adverse health effects, early, mandatory culling, costly veterinary services, and additional
labor for animal care costs [1–3]. It is a well-established disease that affects a high percent-
age of dairy cows and is of particular concern for farmers in both developed and developing
countries [4,5]. Goat farms also suffer economic losses when faced with the burden of
mastitis, which is mainly caused by staphylococcal intramammary infections [6,7].
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North Lebanon is home to extensive dairy farming and production of milk and its
derivatives, which constitute a fundamental part of the Mediterranean diet. Dairy products
are consumed daily by different age categories. The dairy sector in Lebanon is also of
important economic significance. It represents a leading source of income for producers and
families in rural communities, as well as a beneficial opportunity for labor. Approximately
60% of livestock farmers rely on dairy as their main source of income [8]. The development
of the dairy sector in Lebanon has led to excessive use of antimicrobials to improve animal
health by treating clinical signs of infectious diseases, such as mastitis, and therefore
increase their productivity [9]. Several antimicrobial compounds are also currently used as
growth promoters in animal production [10].
Mastitis was reported as the most common cause for antimicrobial administration
in farming [11]. Because it is so widespread, mastitis is a concerning issue in Lebanon,
especially since local farmers and even veterinarians treat infected animals without the
necessary support from laboratory services. Conventional antimicrobials used for mastitis
therapy are consequently showing reduced effectiveness in dairy cattle. The prolonged
misusage of antimicrobial compounds for the treatment of mastitis has contributed to the
emergence of antimicrobial resistance (AMR) [12].
Unfortunately, there is neither enough data on the distribution and circulation of
pathogens involved in mastitis and their susceptibility patterns to antimicrobials nor on
antimicrobial usage in livestock treatment in Lebanon. However, the limited available
reports showed high levels of coliform bacteria contamination in traditional Lebanese
dairy products and many of these isolates are associated with multi-drug resistance
patterns [13,14]. A cross-sectional study also indicated that 27.9% of raw milk samples
in Lebanon are contaminated with extended-spectrum beta-lactamase (ESBL)- and/or
carbapenemase-producing Enterobacterales [14]. Moreover, a high prevalence of ESBL-
producing Escherichia coli isolates (67.5%) was reported among healthy cattle as well as a
remarkable prevalence of ESBL-positive cattle farms (84%) [15]. Similarly, Zouhairi and
colleagues stated that 98.7% of Staphylococcus isolates from Lebanese dairy-based food
products were resistant to at least one antimicrobial drug, with 94% being methicillin-
resistant [16]. Indeed, contaminated dairy products may harbor these antimicrobial re-
sistant microorganisms and may pose a threat to public health by acting as vehicles of
transmission of these pathogens, which will later be responsible for food-borne diseases.
On the other hand, a recent investigation showed the poor knowledge and irresponsibility
of the Lebanese population regarding antimicrobial misuse and resistance [17]. What
makes the situation more alarming is the wide availability of antimicrobials in the Lebanese
market without the requirement of a veterinarian’s prescription [10,18,19].
In this context, the purpose of the current study was to isolate and identify the main
pathogenic bacteria that cause clinical mastitis in dairy farms in Northern Lebanon and
to determine their susceptibility patterns to the most frequent classes of antimicrobials
utilized in veterinary management. This study also investigated the presence of genes
related to AMR, and identified the phylogenetic groups of ESBL- and AmpC-positive
Escherichia coli isolates. We also determined the mosaicism of specific virulence genes
among Staphylococcus isolates.
2. Materials and Methods
2.1. Survey Design
A questionnaire-based survey was performed during March and April 2019 on 45 dairy
farms located in the North of Lebanon. For each participating dairy farm, a record sheet
registering general information about the farm and a short description of the herd (farm
name or area/district, species, clinical signs, percentage of suspected animals, therapy
history, and laboratory tests) was collected at the time of inclusion.
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2.2. Sample Collection
During March and April 2019, 101 mastitis milk samples (90 cow milk samples and
11 goat milk samples) were aseptically collected from 77 dairy cows and 11 goats showing
symptoms of infectious mastitis. Multiple milk samples were at times collected from
different quarters of the same cow. Samples were taken from a total of 45 dairy farms
located in 32 villages in the Northern region of Lebanon. The villages in which the dairy
farms are located are reported in Figure 1. Field veterinarians were responsible for milk
sampling. The material supplied for aseptic sampling included disposable gloves and
towels, alcohol, cotton, 15 mL sterile sampling tubes, and a specific record sheet for each
milk sample. Briefly, teats were cleaned and disinfected using alcohol, the first three
streams were discarded, and then milk samples were collected in sterile 15 mL conical
tubes. The cooled milk samples were transported on the same day in iceboxes directly to
the microbiology laboratory and then processed the same day.
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2.3. Culturing Techniques and Species Identification
Raw milk samples were examined microbiologically by plating 10 µL of each sample
on the following media: Columbia agar with 5% blood; and Columbia CNA Agar with
5% blood, drigalski agar, and mannitol salt agar (all from BioRad, Marnes-la-Coquette,
France). The plates were incubated at 37 ◦C for 24–48 h. Blood agar plates were incubated in
5% CO2. The culture was considered positive if there was a growth of individual bacteria in
a concentration of more than 104 CFU/mL. All isolates were identified and characterized by
matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF
MS) using a VITEK MS instrument (bioMérieux, Marcy l’Etoile, France).
2.4. Antimicrobial Susceptibility Testing
According to the Clinical Laboratory Standard Institute (CLSI) recommendations, bac-
terial isolates were tested for their antimicrobial susceptibility by standard disk diffusion
method either on Mueller–Hinton agar or Mueller–Hinton agar with 5% blood added. The
inhibition zones were measured, recorded, and interpreted according to the CLSI guide-
lines. Minimum inhibitory concentration (MIC) values for all isolates were determined
using a broth microdilution method with 96-well microtitre plates (BOPO6, Sensititre,
Trek Diagnostic Systems, East Grinstead, UK) containing a total of 18 antimicrobials. The
96-well antimicrobial susceptibility plate contained scaled dilutions for the following 18 an-
timicrobials: ceftiofur (XNL) (0.25–8), tiamulin (TIA) (0.5–32), chlortetracycline (CTET)
(0.5–8), gentamicin (GEN) (1–16), florfenicol (FFN) (0.25–8), oxytetracycline (OXY) (0.5–8),
penicillin (PEN) (0.12–8), ampicillin (AMP) (0.25–16), danofloxacin (DANO) (0.12–1), Sul-
fadimethoxine (SDM) (256), Neomycin (NEO) (4–32), Trimethoprim/sulfamethoxazole
(SXT) (2/38), spectinomycin (SPE) (8–64), tylosin tartrate (TYLT) (0.5–32), tulathromycin
(TUL) (1–64), tilmicosin (TIL) (4–64), clindamycin (CLI) (0.25–16), and enrofloxacin (ENR)
(0.12–2). The plates were incubated aerobically at 37 ◦C for 24 h (48 h for Streptococcus spp.)
and were read manually using the Thermo Scientific™ Sensititre™ Manual Viewbox.
2.5. Detection of AMR Genes
The primers and their sequences used in the PCRs are listed in Table S1 of the Supple-
mentary Materials. DNA was extracted by a boiling technique. A loop of bacterial colonies
was put in a test tube containing 1 mL of sterile 10 mM TRIS 1 mM EDTA (T.E) buffer 0.1%
and heated in the Dry Bath (EuroClone, Milan, Italy) at 95 ◦C for 30 min. The solution was
then centrifuged for five minutes at 1000 rpm. The supernatant was collected and used for
the downstream process of PCR. Two multiplex PCR reactions were performed to amplify
ESBL and AmpC beta-lactamase genes in E. coli and Klebsiella oxytoca isolates, as described
by [20]. The first multiplex assay (named Set I) was designed to detect TEM, SHV, CTX-M
IV group, and OXA beta-lactamase encoding genes, and the second assay (named Set II)
was signed to detect CTX-M I group, CTX-M II group, CMY II, and DHA encoding genes.
Additionally, Staphylococcus spp. oxacillin-resistant isolates were tested for the presence of
the mecA and mecC genes for confirmation of methicillin resistance.
2.6. Determination of Phylogenetic Groups
The distribution of phylogenetic groups amongst ESBL- and/or AmpC-producing
E. coli isolates was determined as described by Clermont and colleagues [21]. Eight
phylogroups are now recognized: seven (A, B1, B2, C, D, E, F) belong to E. coli sensu
stricto, whereas the eighth is the Escherichia cryptic clade I. Phylogenetic groups were
identified by multiplex PCR based on the presence or absence of four DNA markers (chuA,
yjaA, DNA fragment TSPE4.C2, and arpA).
2.7. Detection of Biofilm and Virulence Associated Genes of Staphylococcus Spp.
The capability of Staphylococcus spp. to form biofilm is considered an additional
virulence factor in mastitis cases, due to its ability to adhere to and persist in tissues and
the environment [22]. Thus, two separate reactions of PCR were performed to amplify
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biofilm-associated protein (bap) and fragments of the intracellular adhesion (ica) genes
involved in biofilm formation in Staphylococcus spp. as previously described [23]. Moreover,
multiplex PCR assays were carried out to amplify staphylococcal enterotoxins (sea-see, seg,
seh, sei, sej, and sep), exfoliative toxins (eta and etb), and toxic shock syndrome toxin 1 (tsst-1)
genes, as recently described in [24].
3. Results
3.1. Main Findings of the Questionnaire-Based Survey
Our comprehensive questionnaire-based survey revealed that the most prevalent form
of mastitis encountered in our study area was clinical mastitis (92%; 81/88), followed by
subclinical mastitis (8%; 7/88). Animals had at least one of the following symptoms: abnor-
mal milk appearance (presence of blood in milk and/or watery to viscous milk with clots
varying from gray-white to yellowish) (60.2%), hardness and swelling of the udder (47.7%),
and/or reduced milk production (45.4%), inappetence (3.4%), diarrhea (2%), chronic inflam-
mation (1.1%), and/or anorexia (1.1%). Empirical antimicrobial treatment was reported in
four farms using cefaclor (Cefatek®), amoxicillin, tylosin, colistin, gentamicin (10% intra-
muscular injection), and/or a combination of penicillin and kanamycin (Penikan P®). No
laboratory tests were performed before and after antimicrobial prescription, suggesting a
potential misuse of drugs.
3.2. Distribution of Pathogens
In total, sixty-four milk samples (63.4%; 64/101) were positive by conventional culture.
Out of these samples, 73 mastitis-causing pathogens were identified, of which 55 were gram-
positive bacteria (75.3%; 55/73) and 18 were gram-negative bacteria (24.7%; 18/73). After
MALDI-TOF MS analysis, Streptococcus uberis was the predominant bacterial species, followed
by Streptococcus agalactiae, E. coli, Staphylococcus aureus, and Trueperella pyogenes (Table 1).
Table 1. Bacterial isolates from clinical and subclinical bovine and caprine mastitis cases.
Bacterial Species Animal Origin Status of Infection Percentage (%)
Cow Goat Clinical Subclinical
Streptococcus uberis 14 14 19.2
Streptococcus agalactiae 11 11 15.1
Escherichia coli 7 2 9 12.3
Staphylococcus aureus 7 1 8 11
Trueperella pyogenes 5 2 7 9.6
Aerococcus viridans 4 4 5.5
Raoultella ornithinolytica 3 3 4.1
Streptococcus dysgalactiae 2 2 2.7
Streptococcus pluranimalium 1 1 1 1 2.7
Corynebacterium bovis 2 2 2.7
Corynebacterium xerosis 2 2 2.7
Pseudomonas aeruginosa 2 2 2.7
Staphylococcus caprae 1 1 1.4
Staphylococcus haemolyticus 1 1 1.4
Pantoea agglomerans 1 1 1.4
Pasteurella multocida 1 1 1.4
Klebsiella oxytoca 1 1 1.4
Serratia marcescens 1 1 1.4
Streptococcus pneumoniae 1 1 1.4
Total 65 8 66 7 100%
3.3. Antimicrobial Resistance
Selected bacterial species were subjected to AMR studies by disk diffusion and/or
MIC methods including E. coli, K. oxytoca, Pantoea agglomerans, Serratia marcescens, Raoul-
tella ornithinolytica, Pseudomonas aeruginosa, S. aureus, Staphylococcus caprae, Staphylococcus
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haemolyticus, S. uberis, S. agalactiae, and Streptococcus dysgalactiae. According to the CLSI
guidelines, we reported three antimicrobials (oxacillin, erythromycin, and chlorampheni-
col) tested by the disk diffusion method, and ten commonly used antimicrobials (penicillin,
ampicillin, ceftiofur, gentamicin, clindamycin, oxytetracycline, chlortetracycline, florfenicol,
enrofloxacin, and trimethoprim/sulfamethoxazole). Of the eight S. aureus isolates screened,
two (25%) were methicillin-resistant (MRSA). Moreover, the S. haemolyticus isolate was
methicillin-resistant, but the S. caprae isolate was susceptible to methicillin. Regarding E.
coli, all isolates were resistant to ampicillin, but only 11.1% to ceftiofur. Lower levels of
resistance were observed among streptococcal isolates for ampicillin: S. uberis (28.6%), S.
agalactiae (0%), and S. dysgalactiae (0%). Nevertheless, S. agalactiae showed a high resistance
rate against both oxytetracycline and chlortetracycline (100%), followed by S. uberis (92.9%)
and S. dysgalactiae (50%). Similar resistance rates were observed among E. coli isolates
against chlortetracycline (88.9%) and oxytetracycline (77.8%). However, fortunately, lower
resistance rates were reported for florfenicol (55.6%), trimethoprim/sulfamethoxazole
(44.4%), enrofloxacin (22.2%), gentamicin (11.1%), and chloramphenicol (0%). For S. au-
reus isolates, low percentages of resistance to both oxytetracycline and chlortetracycline
(12.5%), gentamicin (12.5%), and enrofloxacin (0%) were observed. The results of antibiotic
resistance of mastitis bacterial pathogens are presented in Table 2. Furthermore, the results
obtained showed the presence of seven (77.8%) multidrug-resistant (MDR) E. coli out of
nine tested isolates, four of which were resistant to three antibiotic classes, and three to
five [25]. In addition, one S. aureus isolate (12.5%) was MDR.
Table 2. Percentage of resistant Enterobacterales, Pseudomonas spp., Staphylococcus spp., and Streptococcus spp. isolates
recovered from milk samples with bovine and caprine mastitis cases.
N PEN ‡ AMP ‡ XNL ‡ GEN ‡ ERY !! CLI ‡ OXY ‡ CTET ‡ CHL !! FFN ‡ ENR ‡ SXT ‡
Escherichia coli 9 - 100 11.1 11.1 - - 77.8 88.9 0 55.6 22.2 44.4
Klebsiella oxytoca 1 - 100 0 0 - - 100 100 0 0 0 0
Pantoea agglomerans 1 - 0 0 0 - - 0 100 0 0 100 0
Serratia marcescens 1 - 100 0 0 - - 100 100 0 100 0 0
Raoultella ornithinolytica 3 - 100 0 0 - - 0 100 0 0 0 0
Pseudomonas aeruginosa 2 - - - 0 - - - - - - 50 -
Staphylococcus aureus 8 62.5 50 - 12.5 0 0 12.5 12.5 0 - 0 0
Staphylococcus caprae 1 100 100 - 0 0 0 0 100 0 - 0 0
Staphylococcus
haemolyticus 1 100 100 - 0 0 0 100 100 0 - 0 0
Streptococcus uberis 14 14.3 28.6 14.3 - 71.4 100 92.9 92.9 42.9 - 50 0
Streptococcus agalactiae 10 0 0 0 - 81.8 100 100 100 18.2 - 100 0
Streptococcusdysgalactiae 2 0 0 0 - 50 50 50 50 50 - 0 0
‡ Determined using the broth microdilution method; !! Determined using the disk diffusion method. PEN—penicillin; OXA—
oxacillin; AMP—ampicillin; XNL—ceftiofur; GEN—gentamicin; ERY—erythromycin; CLI—clindamycin; OXY—oxytetracycline; CTET—
chlortetracycline; CHL—chloramphenicol; FFN—florfenicol; ENR—enrofloxacin; SXT—trimethoprim/sulfamethoxazole.
3.4. Molecular Characterization of Clinical Isolates
Out of the E. coli isolates, five and one were positive for blaTEM and blaCMY-II genes,
respectively. One blaTEM producing E. coli carried an additional blaOXA gene. However,
the K. oxytoca isolate did not harbor any ESBL or AmpC beta-lactamase encoding gene.
Phylogrouping on beta-lactamase-producing E. coli isolates revealed the predominance of
the phylogenetic group B1(4/6; 66.7%), followed by B2 and D (1/6; each). On the other
hand, methicillin resistance was confirmed by the detection of the mecA gene among the
three staphylococcal isolates resistant to oxacillin (two S. aureus and one S. haemolyticus).
None of the isolates harbored the mecC gene.
This report also investigated the presence of adhesin genes and showed that 40% of
staphylococcal isolates were positive for at least one of the classical enterotoxin genes,
and two S. aureus isolates harbored one or more enterotoxin genes. One S. aureus isolate
harbored simultaneously the toxic shock syndrome toxin 1 (tsst-1) and the sec enterotoxin
gene. Regarding biofilm formation genes, all the tested isolates were negative for bap gene,
but all the S. aureus isolates were icaA positive (Table 3). None of the isolates harbored the
exfoliative toxin genes.
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Table 3. Distribution of genes among Staphylococcus spp. isolates.
Isolate Enterotoxins Exfoliative Toxins and ToxicShock Syndrome Toxin-1 Methicillin Resistance Biofilm Formation
S. aureus AL 081 mecA ica operon
S. aureus AL 084 sei, seg mecA ica operon
S. aureus AL 085 ica operon
S. aureus AL 086 ica operon
S. aureus AL 087 ica operon
S. aureus AL 088 ica operon
S. aureus AL 089 sec tsst-1 ica operon
S. aureus AL 090 ica operon
S. haemolyticus AL 091 sea, sej, sep mecA
S. caprae AL 092 seb
4. Discussion
AMR is a growing concern in both human and veterinary medicine in Lebanon [10,18,19].
The extensive use of broad-spectrum antimicrobials in farm animals, the food industry, and
in human and veterinary medicine, has led to the emergence of MDR organisms in humans,
animals, and the environment [9,14,15,18,26–28]. The results of the present study revealed
that most E. coli isolates tested were MDR. Traditional farming and poor hygiene husbandry,
typical of Mediterranean countries including Lebanon, enable the quick spread of resistant
micro-organisms, which represents a major challenge for developing countries, including
Lebanon, as it severely affects the quantity, quality, and safety of animal and food production
with significant economic and social consequences [9,10].
Bacterial infections are the predominant cause of bovine and caprine mastitis. In this
study, we reported 88 cases of clinical and subclinical mastitis. Only 10% of farms admitted
recent administration of antimicrobials. Although 90% of farms did not report the use of
antimicrobials, a non-negligible proportion of farmers are not aware of the proper use of
antimicrobials or their effects on animals and perform false practices, which are at the root
of the spread of AMR [9,10,17]. Several antimicrobials are readily and legally available in
the Lebanese market without the requirement of a veterinarian’s prescription [10].
The analysis of bacterial isolates from bulk milk samples showed the predominance of
gram-positive bacteria, particularly S. uberis, S. agalactiae, and S. aureus, followed by E. coli.
The distribution of mastitis bacterial pathogens varies between different geographic areas
and even countries. For example, S. aureus and coagulase-negative staphylococci (CNS)
have been reported as the most common bovine mastitis in the Middle East, North Africa,
and Europe [29–37]. In the same context, a large-scale epidemiological study conducted in
Italy reported the predominance of S. agalactiae and S. aureus in dairy herds [38]. Moreover,
studies performed in European Mediterranean countries highlighted a significant presence
of E. coli and Staphylococcus spp. [39–42]. Moreover, a high incidence of E. coli was also
observed among bovine mastitis in India and Taiwan [43,44]. In addition, one mastitis
case of Streptococcus pneumoniae was documented. Pneumococcus is a commensal bacterium
that normally colonizes the human nasopharyngeal cavity and is transmitted by droplets
and aerosols either from infected patients or healthy carriers [45]. Although this species is
rarely reported in mastitis, various epidemiological studies showed its high prevalence
in the Lebanese community [46,47]. This allows us to speculate that there is a potential
threat of contamination by handlers. Antimicrobial susceptibility testing showed a high
percentage of resistance among most gram-positive and gram-negative isolates against
both oxytetracycline and chlortetracycline. This is in line with a previous report which
described that 98.4% of streptococcal isolates from dairy cows with mastitis in China were
resistant to tetracycline [48]. In Lebanon, a similar percentage of resistance was observed.
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Most E. coli (82.5%) isolated from healthy adult cattle showed tetracycline resistance [15].
Numerous veterinary infectious diseases among cattle are the most frequently treated with
oxytetracyclines, explaining the high resistance rates observed in this study [49].
In contrast to streptococcal isolates, which showed very low susceptibility results
to erythromycin and clindamycin, none of the staphylococcal isolates showed resistance
to these antimicrobials. Although no similar previous study was found in Lebanon, our
findings are consistent with similar data reported across the world [42,50,51]. In the human
field in Lebanon, a recent cross-sectional study displayed the absence of macrolide and
lincosamide resistance in both MRSA and methicillin-sensitive S. aureus (MSSA) isolates
among food handlers [52]. However, previous Lebanese studies on group A streptococci
human isolates showed lower resistance to erythromycin and clindamycin [53,54].
MRSA was isolated twice (25%) in this study. This percentage is consistent with clinical
human studies at the nationwide level showing a similar prevalence of this resistance
pattern. A compilation of antimicrobial susceptibility data of S. aureus from a network of
13 Lebanese hospitals indicated that 28% were MRSA [55]. Moreover, a previous study
conducted in the same geographic area reported that 23.8% of S. aureus isolates were
MRSA [52]. However, MRSA prevalence in the present study is significantly higher than
that of other countries such as Croatia [56] and Ukraine [57].
Regarding E. coli, 100% and 11.1% of isolates were resistant to ampicillin and cef-
tiofur, respectively. Despite this, only one isolate presented resistance to ceftiofur using
the phenotypic method. Third-generation cephalosporins resistance was screened by
two multiplex PCR reactions as described by [20]. Overall, 55.5% of E. coli isolates were
positive for ESBL and plasmid-mediated AmpC beta-lactamase genes: blaTEM, blaCMY-II,
and/or blaOXA. Unfortunately, due to logistical reasons, this study did not evaluate the
susceptibility of isolates to other third-generation cephalosporins such as cefotaxime, ceftri-
axone, ceftazidime, and cefixime. This study confirmed that food animals and foodstuffs
are a well-known reservoir of ESBL-producing E. coli in Lebanon. Wide dissemination
of third-generation cephalosporin resistance, coupled with resistances to carbapenems,
colistin, and numerous other antimicrobial compounds, has been reported among ani-
mals in the last decade [9,14,15,18,58]. The phylogenetic typing analysis carried out on
the ESBL-producing E. coli isolates revealed that most of them belong to phylogroups B1
(66.7%) followed by both B2 and D (16.7% each), which have previously been reported
in clinical third-generation cephalosporin-resistant isolates in Lebanon [19]. Phylogenetic
grouping is an important approach to understanding the pathogenicity and evolutionary
relationships between different strains [59]. No association was identified between AMR
and phylogroup due to the limited number of E. coli isolates. Thus, a larger study on a
higher number of isolates is needed. At the worldwide level, the majority of E. coli mastitis
strains belong to phylogenetic groups A and B1 [60]. A high frequency of phylogroup B1
was also observed in an Iranian study evaluating the phylogeny of E. coli isolated from
clinical mastitis [61]. A Brazilian study revealed that most E. coli isolates from bovine
mastitis belonged to phylogenetic group A (52%), followed by B1 (38%) [62]. Similarly,
other studies from Ireland, Switzerland, Serbia, and China have noted that E. coli isolates
were mainly assigned to the phylogenetic groups A and B1 [63–67].
The ability of S. aureus isolates to form biofilms is an important mechanism that
reinforces pathogenicity and contributes to AMR. PCR results showed that all S. aureus
isolates were positive for the intracellular adhesion gene icaA, while the bap gene was
not identified in any of the isolates. Our findings follow previous studies conducted in
Poland [68], New Zealand [22], and the United Kingdom [69] that detected the unique
presence of the icaA gene among all S. aureus isolates from bovine mastitis. Our study
also showed that 40% and 25% of staphylococcal and S. aureus isolates were positive for at
least one enterotoxin gene, respectively. Interestingly, one S. aureus isolate simultaneously
harbored tsst-1 and sec genes, predicting the presence of the staphylococcal pathogenicity
island 1 (SaPI1), as described previously [70].
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5. Conclusions
This study provides a consistent source of relevant data on AMR levels and trends of
mastitis bacterial pathogens in Lebanese dairy bovines and caprines. Despite resistance
rate variations, our findings confirmed the wide dissemination of antimicrobial-resistant
bacteria in the Lebanese dairy industry. Many causative agents isolated in this study are
zoonotic and can be transmitted directly between animals and humans or through the
food chain. Therefore, there is a drastic need for a national strategy based on the one
health approach to address the AMR issue and regulate the usage of antimicrobials in
the veterinary sector in Lebanon, including bans on over-the-counter drugs and growth
promoters. Additionally, the training and education of farmers is necessary to create
awareness of AMR through effective communication, education, and training. Further
large-scale, nationwide studies are also needed to evaluate the correlations between the
use of antimicrobials in common husbandry practices and the onset of AMR in Lebanon.
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